- Presentations
- 3
- Markets
- 1
Onfi is a brand of Clobazam marketed by Lundbeck Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Clobazam
- Brand owner
- Lundbeck Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 2.5 mg/mL oral suspension, 10 mg tablet, 20 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Onfi 2.5 mg/mL oral suspensionOral | Lundbeck Pharmaceuticals | US FDA | Available on request |
| Onfi 10 mg tabletOral | Lundbeck Pharmaceuticals | US FDA | Available on request |
| Onfi 20 mg tabletOral | Lundbeck Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Clobazam.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Onfi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.